These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 1691866)
1. Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas. Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H Surg Neurol; 1990 May; 33(5):320-4. PubMed ID: 1691866 [TBL] [Abstract][Full Text] [Related]
2. Nucleolar organizer region score and Ki-67 labelling index in high-grade gliomas and metastatic brain tumours. Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H Acta Neurochir (Wien); 1991; 109(1-2):37-41. PubMed ID: 1648862 [TBL] [Abstract][Full Text] [Related]
3. Nucleolar organizer regions in vascular and neoplastic cells of human gliomas. Hara A; Sakai N; Yamada H; Hirayama H; Tanaka T; Mori H Neurosurgery; 1991 Aug; 29(2):211-5. PubMed ID: 1715979 [TBL] [Abstract][Full Text] [Related]
4. A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma. Hall PA; Crocker J; Watts A; Stansfeld AG Histopathology; 1988 Apr; 12(4):373-81. PubMed ID: 2453436 [TBL] [Abstract][Full Text] [Related]
5. Proliferative potential of human brain tumours as assessed by nucleolar organizer regions (AgNORs) and Ki67-immunoreactivity. Plate KH; Rüschoff J; Behnke J; Mennel HD Acta Neurochir (Wien); 1990; 104(3-4):103-9. PubMed ID: 1701284 [TBL] [Abstract][Full Text] [Related]
6. Argyrophilic nucleolar organizer region counts and Ki-67 scores in human renal cell carcinoma. Pich A; Valente G; Azzoni L; Stramignoni A; Margaria E; Tasso M Pathol Res Pract; 1991 May; 187(4):482-6. PubMed ID: 1715079 [TBL] [Abstract][Full Text] [Related]
7. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions. Brustmann H; Naudé S Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828 [TBL] [Abstract][Full Text] [Related]
8. Sequential demonstration of nucleolar organizer regions and Ki67 immunolabelling in non-Hodgkin's lymphomas. Janmohamed RM; Murray PG; Crocker J; Leyland MJ Clin Lab Haematol; 1990; 12(4):395-9. PubMed ID: 2081380 [TBL] [Abstract][Full Text] [Related]
9. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor. Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045 [TBL] [Abstract][Full Text] [Related]
10. Actual proliferating index in oral squamous cell carcinoma and leukoplakia. Chandak AR; Gadbail AR; Chaudhary MS; Chandak SA; Wadhwani R J Investig Clin Dent; 2011 Aug; 2(3):176-83. PubMed ID: 25426788 [TBL] [Abstract][Full Text] [Related]
11. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer]. Zhao T; Zhang YL; Li CD Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415 [TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections. Korkolopoulou P; Christodoulou P; Papanikolaou A; Thomas-Tsagli E Am J Surg Pathol; 1993 Sep; 17(9):912-9. PubMed ID: 8102513 [TBL] [Abstract][Full Text] [Related]
13. Relationship between Ricinus communis agglutinin-1 binding and nucleolar organizer regions in human gliomas. Niikawa S; Hara A; Shirakami S; Zhang W; Sakai N; Yamada H; Shimokawa K Neurol Med Chir (Tokyo); 1993 Jun; 33(6):345-9. PubMed ID: 7689179 [TBL] [Abstract][Full Text] [Related]
14. Nucleolar organizer regions (AgNORs) in primary and recurrent gliomas. A retrospective study. Engel U; Plate K; Jänisch W; Mennel HD Zentralbl Pathol; 1994 Mar; 140(1):73-81. PubMed ID: 7515677 [TBL] [Abstract][Full Text] [Related]
15. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease. Kale A; Söylemez F; Ensari A Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454 [TBL] [Abstract][Full Text] [Related]
16. AgNOR- and PCNA-studies in astrocytomas of the optic nerve. Patt S; Giraldo M; Martin H Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678 [TBL] [Abstract][Full Text] [Related]
17. Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme. Onda K; Davis RL; Wilson CB; Hoshino T Acta Neuropathol; 1994; 87(6):586-93. PubMed ID: 8091951 [TBL] [Abstract][Full Text] [Related]
18. Proliferative potential of brain tumors. Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nuclear organizer region counts. Shibuya M; Ito S; Miwa T; Davis RL; Wilson CB; Hoshino T Cancer; 1993 Jan; 71(1):199-206. PubMed ID: 8416716 [TBL] [Abstract][Full Text] [Related]
19. Proliferative assessment of GFAP-positive and GFAP-negative glioma cells by nucleolar organizer region staining. Hara A; Sakai N; Yamada H; Niikawa S; Ohno T; Tanaka T; Mori H Surg Neurol; 1991 Sep; 36(3):190-4. PubMed ID: 1652162 [TBL] [Abstract][Full Text] [Related]
20. Argyrophilic nucleolar organizer regions and proliferating cell nuclear antigen/cyclin in Kaposi's sarcoma. Comparison with morphology and with immunoperoxidase staining for factor VIII-related antigen. Haupt HM; Stern JB; Multhaupt H; Newman HW Arch Pathol Lab Med; 1995 Jun; 119(6):538-41. PubMed ID: 7605171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]